The new agenda outlines the objectives of the Center for Veterinary Medicine.
The U.S. Food and Drug Administration (FDA) announced modernization of its approach to innovative animal and veterinary products. The agency’s Animal and Veterinary Innovation Agenda outlines objectives to support product development and update regulatory approaches for modern animal and veterinary products.
“The FDA is committed to helping developers bring products that enhance public health, animal health, and food production to market while providing consumers with confidence that they meet the FDA’s high standards,” said FDA Commissioner Robert M. Califf. “This comprehensive agenda is intended to accelerate smart regulatory pathways and enhance continued public confidence in the FDA’s regulation of these products, while avoiding unnecessary barriers to future industry advancements.”
The agency also stated it is collaborating with Congress to establish new approval pathways for certain substances and optimizing regulatory processes for greater clarity and predictability.
As the Lord Leads, Pray with Us…
- For Commissioner Califf as he collaborates with the Center for Veterinary Medicine (CVM) on the new objectives.
- For CVM Director Tracey Forfa as she works with FDA Chief Scientist Namandjé Bumpus to implement the innovation and regulatory standards.
- For the president and administration officials as they determine ways to integrate technology into food, drugs, and other health devices.
Sources: Food and Drug Administration
